-
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaBhatt DL, Steg PG, REDUCE-IT Investigators. -
Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium ScoringJD Mitchell, N Fergestrom, BF Gage et al.
-
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding RiskP Urban, R Mehran, R Colleran et al.
-
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery DiseaseMB Tsang, JD Schwalm, S Gandhi et al.
-
Level of Scientific Evidence Underlying the Current American College of Cardiology/American Heart Association Clinical Practice GuidelinesBevan GH, Kalra A, Josephson RA, Al-Kindi SG
-
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysisM Biswas, SK Kali.
-
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary RevascularizationH Kawashima , PW Serruys, and on behalf of the SYNTAX Extended Survival Investigators et al.
-
The Year in Cardiovascular Medicine 2020: Coronary InterventionM Nicholls.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
